ArticleComputational and structural biotechnology journal2025
Identification of transglutaminase 2 mediated polyaminated proteins in a hepatocellular cancer cell line.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyamines are abundant metabolites that are involved in many cellular processes. Despite playing wide-ranging and essential roles in the cell, only a few examples of a specific polyamine function are known. Polyamination is the post-translational modification of a protein by polyamines (putrescine, spermidine or spermine). This reaction is catalyzed by transglutaminases (primarily TGM2) via a transamidation reaction that conjugates a polyamine to an acceptor glutamine in a target protein. Protein polyamination is poorly characterized due to technical challenges in detecting the polyaminated adduct, and is neglected in most proteomic surveys. We performed polyamination reactions using whole cell lysates from a mouse liver cancer cell line with elevated TGM2 expression. Two differently tagged polyamine analogs (Biotin-pentylamine and DNP-pentylamine) with distinct molecular masses were used, and the respective modified peptides were identified by mass spectrometry. 51 protein targets modified on 66 different sites were identified, in some cases with both donor polyamines. Many of the targets are involved in translation or cytoskeletal organization, and implicated in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.